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Key points summary 
 In an anaesthetized animal model, independent stimulation of baroreceptors 
in the pulmonary artery elicits reflex sympathoexcitation.  
 In humans, pulmonary arterial pressure is positively related to basal MSNA 
under conditions where elevated pulmonary pressure is evident (e.g. high-
altitude); however, a causal link is not established. 
 Using a novel experimental approach, we demonstrate that reducing 
pulmonary arterial pressure lowers basal MSNA in healthy humans.  
 This response is distinct from the negative feedback reflex mediated by aortic 
and carotid sinus baroreceptors when systemic arterial pressure is lowered. 
 Afferent input from pulmonary arterial baroreceptors may contribute to 
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Abstract 
In animal models, distension of baroreceptors located in the pulmonary artery 
induces a reflex increase in sympathetic outflow; however, this has not been 
examined in humans. Therefore, we investigated whether reductions in pulmonary 
arterial pressure influenced sympathetic outflow and baroreflex control of muscle 
sympathetic nerve activity (MSNA). Healthy lowlanders (n=13; 5 females) were 
studied 4-8 days following arrival at high-altitude (4383m; Cerro de Pasco, Peru), a 
setting that increases both pulmonary arterial pressure and sympathetic outflow. 
MSNA (microneurography) and blood pressure (BP; photoplethysmography) were 
measured continuously during 1) ambient air breathing (Amb) and 2) a six-minute 
inhalation of the vasodilator nitric oxide (iNO; 40ppm in 21% O2), to selectively lower 
pulmonary arterial pressure. A modified Oxford test was performed under both 
conditions. Pulmonary artery systolic pressure (PASP) was determined using 
Doppler echocardiography. iNO reduced PASP (24±3 vs 32±5 mmHg; P <0.001) 
compared to Amb, with a similar reduction in MSNA total activity (1369±576 to 
994±474 a.u·min-1; P = 0.01). iNO also reduced the MSNA operating point (burst 
incidence; 39±16 to 33±17 bursts·100 Hb-1; P = 0.01) and diastolic operating 
pressure (82±8 to 80±8 mmHg; P < 0.001) compared to Amb, without changing heart 
rate (P= 0.6) or vascular-sympathetic baroreflex gain (P = 0.85). In conclusion, 
unloading of pulmonary arterial baroreceptors reduced basal sympathetic outflow to 
the skeletal muscle vasculature and reset vascular-sympathetic baroreflex control of 
MSNA downward and leftward in healthy humans at high-altitude. These data 
suggest the existence of a lesser-known reflex input involved in sympathetic 
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Introduction 
In animal models, distension of pulmonary arterial baroreceptors, whilst 
carefully controlling the distending pressure to other major reflexogenic areas, elicits 
reflex sympathoexcitation and systemic vasoconstriction (Ledsome and Kan, 1977; 
Mcmahon et al., 2000; Moore et al., 2011). Strikingly, these baroreceptors, located at 
the pulmonary artery bifurcation and in the extrapulmonary artery branches, elicit 
sympathetic responses that contrast with reflex sympathoinhibition and the resulting 
systemic vasodilation elicited by isolated distension of carotid sinus baroreceptors in 
the same experimental preparation (Moore et al., 2011). Moreover, an interaction 
exists between pulmonary arterial and carotid sinus baroreceptors, whereby altering 
pressure within the pulmonary arteries acutely resets the vascular limb of the carotid 
sinus baroreflex with unaltered reflex gain (Moore et al., 2011). In contrast to these 
studies, a role for pulmonary arterial baroreceptors in sympathetic activation in 
humans has been largely unexplored, likely due to the difficulty in isolating a 
physiological stimulus to the pulmonary circulation.  
Some indirect support for a sympathoexcitatory reflex originating from 
baroreceptors in the pulmonary circulation of humans is evident in the literature. 
First, although  a causal relationship has not been established, pulmonary arterial 
pressure is positively related to basal MSNA under conditions of elevated pulmonary 
arterial pressure, including exposure to high-altitude hypoxia (Duplain et al., 1999), in 
heart failure (Ferguson et al., 1990) and in pulmonary arterial hypertension (Velez-
Roa et al., 2004). Second,  approximately a quarter of single-unit muscle 
sympathetic efferent fibres display an increase in neural activity during non-
hypertensive lower body positive pressure (LBPP), a manoeuvre that increases 
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during non-hypotensive lower body negative pressure (LBNP), which reduces right-
sided filling pressure (Millar et al., 2013; Millar et al 2015; Incognito et al., 2018). 
Together, given the strong evidence from animal studies and supporting evidence in 
humans, we believe that a potential role for pulmonary arterial baroreceptors in 
sympathetic neural activation in humans requires investigation.  
Therefore, the aim of the present study was to investigate the mechanistic 
role of pressure sensitive receptors in the pulmonary circulation in control and 
regulation of sympathetic outflow in humans. To investigate this, we employed a 
novel experimental paradigm to isolate the pulmonary baroreceptors. Healthy 
lowlanders were studied at high-altitude, a setting known to increase pulmonary 
arterial pressure (Naeije., 1992). Basal MSNA and baroreflex control of MSNA were 
assessed whilst breathing ambient air and during inhalation of the selective 
pulmonary vasodilator nitric oxide (NO) (Frostell et al., 1991; Pepke-Zaba et al., 
1991), to reduce the pressure stimulus to baroreceptors in the pulmonary circulation, 
without altering the stimulus to systemic arterial baroreceptors. Based on available 
evidence in animals, we hypothesised that reducing pulmonary artery pressure 
would reduce MSNA in healthy humans at high-altitude and reset baroreflex control 
of MSNA.  
Methods 
Ethical approval  
All experimental procedures had Institutional Review Board approval from the 
University of British Columbia (HS17-02687) and conformed to the latest revision of 
the Declaration of Helsinki, except for registration in a database. Prior to 
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formed part of the Global REACH expedition to the Universidad Peruana Cayetano 
Heredia’s Instituto de Investigacions de Altura (4383m; Cerro de Pasco, Peru) in July 
2018. Participants took part in a number of other studies; however, care was taken to 
ensure no overlap existed between studies and the present study addressed a 
distinct a priori research question.  
Participants 
Thirteen lowlanders (5 females) mean age (28 ± 7 yrs), height (1.7 ± 0.1 m) and 
weight (71 ± 7 kg) free from cardiovascular, respiratory, metabolic and neurological 
disease were recruited. Participants rapidly ascended from sea-level (SL) to 4383m 
over the course of 9–10 h by motor vehicle and were studied 4-8 days (5 ± 2 days) 
following arrival at 4383m (High altitude, HA; Cerro de Pasco, Peru; barometric 
pressure, 455 ± 0.7 mmHg). All participants were asked to abstain from caffeine, 
alcohol and vigorous exercise for at least 12 hours prior to the experimental session 
and arrived at the laboratory a minimum of 4 hours after a light meal. On the day of 
testing, participants completed the Lake Louise Acute Mountain Sickness (AMS) 
questionnaire (Roach et al., 2018) to evaluate symptoms of AMS. Twelve 
participants reported a Lake Louise Score (LLS) ≤3 and did not have clinically 
defined AMS. One subject was administered medication for treatment of AMS 4 days 
following arrival at high-altitude [two doses of 125mg acetazolamide over 24 hours], 
but was tested following a 72 hour washout period. The washout allowed sufficient 
clearance time (i.e. >48 h) before experimental data were collected, since the 
reported half‐life for acetazolamide is ∼10 h (Ritschel et al., 1998)  and this low‐dose 
quantity is reported to be 90–100% excreted within 24 h of administration (Richalet 
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therefore, experiencing mild AMS at the time of participation. None of the 
participants were taking any prescription or over-the-counter medication at the time 
of participation. Based upon self-reporting, three females were tested in the early-
follicular phase, one in the late-follicular phase of their menstrual cycle and one in 
the low-hormone phase of oral contraceptive use. 
Experimental protocol 
Following arrival at the laboratory, subjects rested in the supine position and an 
antecubital venous cannula was inserted for subsequent drug administration. 
Following instrumentation, acquisition of an acceptable MSNA signal, and a period of 
stabilisation, a single modified Oxford test was performed to determine vascular-
sympathetic baroreflex function during ambient air breathing (Amb). Briefly, the 
modified Oxford test involved bolus injection of sodium nitroprusside followed 90 
seconds later by phenylephrine, as described previously in detail (Rudas et al., 1999; 
Simpson et al., 2019). Participants were then transferred to breathing room air via a 
mouthpiece and noseclip. Following a period of stabilisation, subjects rested for 5 
minutes to determine baseline cardiovascular and pulmonary hemodynamics and 
sympathetic neural activity. Subjects were then switched to breathing a gas mixture 
containing 21% oxygen and 40ppm Nitric Oxide (iNO) from a Douglas bag. Following 
six minutes of iNO, a second modified Oxford test was performed. During the 
modified Oxford test, subjects continued to breathe iNO. Modified Oxford tests were 
separated by a minimum of 20 minutes. 
Inhaled Nitric Oxide 
Inhaled NO rapidly diffuses across the alveolar-capillary membrane into the 
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induces vascular smooth muscle relaxation (Steudel et al., 1999). NO that diffuses 
into the intravascular space rapidly binds to haemoglobin, which serves to inactivate 
NO (Rimar & Gillis, 1993) and prevent systemic vasodilation (Frostell et al., 1991; 
Pepke-Zaba et al., 1991). Therefore, inhaled NO acts as a selective pulmonary 
vasodilator. NO was diluted in 100% nitrogen (N2) in a Douglas bag, to prevent the 
production of nitrogen dioxide. Immediately prior to inhalation, the NO/N2 gas mixture 
was titrated with 100% Oxygen (O2) to obtain a gas mixture containing 21% O2, 79% 
N2 and 40ppm NO (ML206; ADInstruments, Colorado Springs, CO, USA). O2 and 
NO gas concentrations were verified and nitrogen dioxide concentration was 
measured to ensure levels remained below 5ppm. 
Experimental measurements 
Cardiovascular and pulmonary haemodynamics 
Heart rate (HR) and blood pressure (BP) were continuously recorded using 
electrocardiogram (ECG; Lead II) and finger photoplethysmography, respectively 
(Finometer MIDI, Finapres Medical Systems BV, Amsterdam, Netherlands). Systolic 
(SBP), diastolic (DBP) and mean (MAP) pressures were calculated on a beat-by-
beat basis from the finger arterial pressure waveform. Finometer values were 
calibrated against the average of three brachial artery blood pressure measurements 
taken during the baseline period. Peripheral oxygen saturation (SpO2) was 
determined using finger pulse oximetry (Nellcor, Medtronics, USA). Echocardiograhy 
was used to assess left ventricular stroke volume (SV) and pulmonary artery systolic 
pressure (PASP). Images were obtained using a commercially available system 
(Vivid Q, GE, Fairfield, CT, USA) and stored for subsequent off-line analysis. Images 
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chamber views in line with the American Society of Echocardiography guidelines for 
the assessment of the right and left heart (Lang et al., 2005, 2015; Rudski et al., 
2010). SV was calculated from the Doppler signal using the velocity-time integral and 
the aortic cross section area (π*aortic diameter2·4-1). Cardiac output (Qc) was 
calculated as the product of HR and SV. PASP was quantified as the maximum 
systolic pressure gradient across the tricuspid valve added to right atrial pressure 
estimated from the collapsibility of the inferior vena cava, in line with the guidelines 
of the American Society of Echocardiography (Rudski et al., 2010). To derive 
pressure, the modified Bernoulli equation (4·V2) was applied to the peak systolic 
regurgitation jet velocity measured via continuous wave Doppler (Rudski et al., 
2010).  
Muscle sympathetic nerve activity  
Multi-unit MSNA was recorded from the peroneal nerve via microneurography as 
previously described (Hagbarth & Vallbo, 1968; Sundlof & Wallin, 1978). The MSNA 
signal was confirmed by pulse-synchronous activity that responded to end-expiratory 
apnea but not to startle stimuli or skin stroking (Delius et al., 1972). Nerve signals 
were acquired (Neuroamp EX headstage, ADInstruments, Sydney, Australia), 
amplified (100,000x), filtered (band pass 700-2,000Hz), rectified and integrated 
(decay constant 0.1s) (LabChart Pro v8.3.1, ADInstruments, Sydney, Australia). No 
adverse events or complications occurred during or following the microneurography 
procedure in any subject. 
Data analyses  
All haemodynamic data were sampled at 1 KHz using a commercial data acquisition 
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offline analysis. The raw MSNA signal was sampled at 10 KHz. Multi-unit bursts of 
MSNA were identified using an automated detection algorithm (Chart Pro 8.3.1) and 
confirmed using established criteria (White et al., 2015) by a trained observer (LLS), 
who performed data analysis whilst blinded to the condition. To account for 
differences in microelectrode position, burst amplitude data were normalised by 
assigning a value of 100 to the largest burst observed during baseline. All other 
bursts were calibrated against this value. Resting MSNA was quantified as burst 
frequency (burst·min-1), burst incidence (burst·100HB-1), mean burst amplitude (a.u) 
and total activity (mean burst amplitude x burst frequency [au·min-1]) and total MSNA 
(mean burst amplitude x burst incidence [burst·100HB-1]). A single sonographer 
(TGD), who was blinded to the condition, analyzed echocardiography images. 
Vascular-sympathetic baroreflex function 
Vascular-sympathetic baroreflex gain was estimated from the relationship 
between 1) DBP and MSNA burst probability and 2) DBP and total MSNA during a 
“gold standard" modified Oxford test. All DBP values were assigned to a 3 mmHg bin 
to reduce the statistical impact of non-baroreflex influences. The percentage of 
cardiac cycles associated with a burst of MSNA (ranging from 0-100%) was 
calculated for each DBP bin to give values for MSNA burst probability. To determine 
the relationship between total MSNA and DBP the sum of normalized burst 
amplitudes for each DBP bin was determined. This value was then divided by the 
number of bursts within that DBP bin, to calculate mean burst amplitude (Usselman 
et al., 2015). Mean burst amplitude was then multiplied by the burst probability to 
calculate total MSNA. The slope of the linear relationship was determined by 
weighted linear regression analysis, and this value provided an index of vascular-
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0.5 were included in the group mean data (Simpson et al., 2019).  Vascular-
sympathetic baroreflex gains for rising and falling pressures were not determined 
independently. The vascular-sympathetic baroreflex operating point was taken as the 
average values for DBP and MSNA burst incidence or Total MSNA during 5 minutes 
of the Amb condition immediately prior to the start of iNO,and during the last 5 
minutes of iNO. Participants breathed with a mouthpiece during both periods. 
Furthermore, baroreflex gain was also assessed from the slope of linear regression 
analyses relating burst probability and total MSNA to corresponding spontaneous 
fluctuations in DBP during each of these 5-minute periods. Only values that met the 
previously described criteria were included in subsequent statistical analyses.  
Statistical analyses 
Significant vascular-sympathetic baroreflex slopes were not obtained in 2 out of 13 
participants (R≥ 0.5) and a modified Oxford test was not performed in one participant 
during iNO; therefore, repeated measure comparisons for vascular-sympathetic 
baroreflex gain are limited to 10 participants. Spontaneous baroreflex slopes were 
not obtained in 5 out of 13 participants (R≥ 0.5); therefore, repeated measure 
comparisons for spontaneous baroreflex gain are limited to 8 participants. Values for 
cardiovascular haemodynamics and sympathetic neural activity during iNO were 
calculated by averaging over the last 5 minutes of NO inhalation and were compared 
to the 5 minutes ambient air breathing immediately preceding the start of inhalation. 
Pulmonary haemodynamics were determined between minutes one and two, and 
between minutes five and six of NO inhalation. The duration of inhalation had no 
effect on pulmonary haemodynamics (i.e. PASP values determined after one minute 
were not different from those measured after five minutes). Therefore, values for 
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measurements taken at each time-point. The effects of iNO on cardiovascular and 
pulmonary hemodynamics, MSNA, and sympathetic baroreflex gain were assessed 
using paired t-tests. Normality was assessed using Shapiro-Wilk test, and data that 
was not normally distributed underwent log10 transformation prior to analysis. All 
statistical analyses were performed using Prism 7.03 (GraphPad software, USA) and 
statistical significance was set at P<0.05 a priori. Group data are reported as means 
(± SD).  
Results  
Effect of iNO on pulmonary, cardiovascular haemodynamics and basal sympathetic 
neural activity 
By design, inhalation of NO reduced PASP compared to Amb (Table 1). MSNA total 
activity was also significantly reduced during iNO. An example of MSNA and 
haemodynamic data recorded in one subject during Amb and iNO is presented in 
Figure 1. The relationship between MSNA total activity and PASP during Amb and 
iNO is shown in Figure 2. There was, however, no significant relationship between 
the ∆PASP and ∆MSNA total activity (r = 0.32, P = 0.29), or ∆PASP and ∆MSNA 
burst frequency (r = 0.27, P = 0.38). The reduction in total activity was mediated by a 
reduction in MSNA burst frequency with no change in mean burst amplitude 
compared to Amb (Table 1). There was a small, but significant, reduction in systemic 
SBP, DBP and MAP during iNO compared to Amb, with no change in HR, SV, Qc or 
SpO2 (Table 1).  
Effect of iNO on vascular-sympathetic baroreflex function 
Inhalation of NO significantly reduced diastolic operating pressure (82 ± 8 to 80 ± 8 
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bursts·100HB-1; P = 0.01: total MSNA, 1882 ± 862 to 1479 ± 891 a.u·100HB-1; P = 
0.02), indicating a leftward and downward resetting of the vascular-sympathetic 
baroreflex during iNO (Figure 3). The mean slope of the linear portion of the 
baroreflex curve was similar during iNO and Amb, regardless of whether MSNA was 
quantified as burst probability (-3.4 ± 1.7 to -3.5 ± 1.8 %·mmHg-1; P = 0.85) or total 
MSNA (-204 ± 108 to -216 ± 83 au·mmHg-1; P = 0.7), indicating no differences in 
vascular-sympathetic baroreflex gain (Figure 3). Similarly, the mean slope of the 
linear portion of the relationship between MSNA and spontaneous changes in arterial 
pressure, was comparable during the iNO and Amb conditions, regardless of 
whether MSNA was quantified as burst probability (-3.0 ± 1.5 %∙mmHg-1 to -3.2 ± 0.9 
%∙mmHg-1; P = 0.84) or total MSNA (-186 ± 135 to -197 ± 144 au·mmHg-1; P = 0.88) 
Discussion 
The key novel findings from this study are twofold: 1) lowering arterial pressure in the 
pulmonary circulation alters the prevailing level of MSNA, providing first-in-human 
evidence of afferent input from pulmonary arterial baroreceptors regulating 
sympathetic neural outflow; and 2) pulmonary arterial pressure influences the set-
point of the vascular-sympathetic baroreflex, providing a mechanism contributing to 
vascular-sympathetic baroreflex resetting during high-altitude exposure.   
Sympathetic neural activation by pulmonary arterial baroreceptors 
The existence of vagal afferent fibres whose firing is related to pulmonary 
arterial pressure changes, has been known for a long time (Bianconi & Green, 1959; 
Coleridge & Kidd, 1961). In anesthetized non-hypoxic animals, isolated distension of 
these baroreceptors, located at the pulmonary artery bifurcation and in the 
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(Ledsome and Kan, 1977; Moore et al., 2011). Furthermore, pulmonary arterial 
baroreceptor distension resets carotid baroreflex control of the peripheral 
vasculature (Moore et al., 2011) to operate at higher levels of sympathetic nerve 
activity and systemic pressure. Until now, however, the physiological role of these 
receptors in humans has not been investigated, presumably due to the technical 
difficulty in isolating a physiological stimulus to the pulmonary vasculature in a 
closed-loop system. In an attempt to overcome this challenge, we studied healthy 
lowlanders at high-altitude, before and during inhalation of nitric oxide (iNO), an 
intervention shown to reduce pulmonary arterial pressure without altering systemic 
arterial pressure (Frostell et al., 1991; Pepke-Zaba et al., 1991). With this approach, 
pulmonary arterial systolic pressure was lowered by 20%, which was accompanied 
by a 25% reduction in MSNA total activity. However, the magnitude of the response 
(i.e. ∆MSNA ) was not related to the magnitude of stimulus (i.e. ∆PASP), which is 
likely due to individual differences in both the location of the operating point on the 
stimulus-response curve and the responsiveness of the reflex (i.e. gain). Whilst the 
reduction in MSNA during iNO also occurred in parallel to a small reduction in 
systemic arterial pressure, this would have been expected to evoke an increase in 
MSNA via arterial baroreflex buffering. Strikingly, MSNA total activity was remarkably 
stable in one subject who did not display a reduction in PASP during iNO. Therefore, 
we interpret that the reduction in MSNA observed during iNO was mediated by 
unloading of the pulmonary arterial baroreceptors. Notably, this response is 
directionally opposite to the sympathetic response elicited during unloading of the 
systemic arterial baroreceptors.  
As the human circulation is an integrated closed-loop system, changes to 
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response. Thus, several alternative interpretations of our data require discussion. 
First, an increase in atrial pressure is proposed to activate single-unit MSNA in 
healthy humans (Millar et al., 2013; Incognito et al., 2018). However, in contrast, 
when a stimulus is localized precisely to the left atria-pulmonary vein junction of 
anaesthetized dogs, atrial receptor activation has no effect on sympathetic efferent 
activity in lumbar nerves, which is an analogue of human MSNA (Karim et al., 1972). 
Notably, neither atrial receptor stimulation (Carswell et al., 1970) nor changes in 
ventricular filling (Drinkhill et al., 2001) affect systemic vascular resistance in 
anaesthetized dogs. Thus, whilst we acknowledge differences may exist between 
anaesthetized dogs and conscious humans, in our view, the intrathoracic receptors 
most likely to elicit the observed MSNA response are those located in the pulmonary 
artery and its bifurcation (Moore et al., 2004a, 2004b). Furthermore, studies that 
have employed invasive haemodynamic measurements report no change in right 
atrial pressure and pulmonary capillary wedge pressure from sea level to high-
altitude (6100m), despite an increase in pulmonary artery mean pressure from 15 to 
24 mmHg (Reeves et al., 1987; Groves et al., 1987). Therefore, right and left atrial 
pressure would not necessarily be expected to change during the reduction in PASP 
observed during iNO in the present study. Second, we cannot reject some 
contribution by the arterial baroreflex. Notably, arterial baroreceptors respond to 
deformation of the arterial wall and not arterial pressure per se (Angell-James, 
1971). Therefore, a small change in stroke volume, independent of arterial pressure, 
could alter baroreceptor afferent activity and influence the observed MSNA response 
(Lacolley et al., 1992; Taylor et al., 1995; Fu et al., 2008). Closer inspection of our 
data, however, reveals a variable change in SV during iNO; that is, SV increased in 
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of 13 participants. Along with the previously discussed small decrease in arterial 
blood pressure, this variability in the SV response suggests that the arterial 
baroreflex did not mediate the observed decrease in MSNA.  
Inhalation of NO resulted in a small, non-significant increase in SpO2; 
therefore, a reduced peripheral chemoreceptor drive may have mediated the 
reduction in MSNA. We cannot ignore this possibility, although we and others have 
demonstrated no change in MSNA with administration of 100% oxygen at high-
altitude (Hansen & Sander, 2003; Simpson et al., 2019). Furthermore, we did not 
observe a significant relationship between the change in SpO2 and change in MSNA 
(r = -0.16, P = 0.61) in the present study. Finally, whilst any NO that enters the 
circulation is rapidly inactivated (Rimar & Gillis, 1993), an increased central NO 
bioavailability, via the nitrate-nitrite-NO pathway may have influenced the MSNA 
response (Owlya et al., 1997; Young et al., 2009; Notay et al., 2017). However, no 
change in plasma nitrite levels were previously reported in healthy subjects during a 
60 minute inhalation of 25ppm iNO (Westfelt et al., 1995).   
 
Interaction between pulmonary arterial baroreceptors and arterial baroreflex 
Interestingly, the reduction in MSNA total activity was mediated by a reduction 
in burst occurrence, with no change in burst amplitude. Kienbaum et al. (2001) 
proposed two central sites for modulation of sympathetic outflow, where the arterial 
baroreflex determines the occurrence of sympathetic bursts, however, other 
peripheral inputs largely determine the size of those bursts. As such, it appears that 
afferent input from pulmonary arterial baroreceptors alter sympathetic outflow by 
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between the two groups of baroreceptors, whereby unloading of the pulmonary 
arterial baroreceptors (i.e. lowering pulmonary arterial systolic pressure) did not 
change the MSNA responsiveness to acute increases and decreases in arterial 
pressure (i.e. gain), but reset sympathetic neural activity and diastolic pressure to 
lower levels. Thus, there was a downward and leftward resetting of the arterial 
baroreflex control of MSNA. This is consistent with work in experimental animals that 
report an upward and rightward resetting of the carotid baroreflex control of vascular 
resistance, with no change in gain, during increases in pulmonary arterial pressure 
(Moore et al., 2011).  
In the present study, we observed a small, but significant, reduction in 
diastolic blood pressure (~2mmHg) during reductions in pulmonary arterial systolic 
pressure. Using individual stimulus-response relationships, we estimate that such a 
reduction in diastolic pressure should increase the probability of a burst by around 5 
to 6% (i.e. 5 - 6 bursts·100Hb-1), via engagement of the arterial baroreflex. In fact, we 
observed the opposite, a reduction of 6 bursts·100Hb-1. We interpret a lack of reflex 
sympathoexcitation as further confirmation that the set-point of the vascular-
sympathetic baroreflex is reset when the prevailing arterial pressure in the 
pulmonary circulation changes. Recently, we observed an upward resetting of the 
vascular-sympathetic limb of the arterial baroreflex during chronic exposure (10-21 
days) of healthy lowlanders to high-altitude (Simpson et al., 2019). Furthermore, 
reducing peripheral chemoreceptor drive, via administration of 100% oxygen, did not 
reverse this resetting, leaving the potential mechanism(s) unclear. The mechanism 
presented and discussed here, therefore, may play a role; that is, afferent feedback 
from pulmonary arterial baroreceptors contributes to resetting of arterial baroreflex 
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Experimental limitations 
First, the present study characterizes the neural response to a reduction in 
pulmonary arterial pressure only. Primarily, this was due to the difficultly in elevating 
pulmonary arterial pressure independently in conscious humans. All the same, a 
study performed under non-hypoxic conditions observed marked suppression of 
MSNA during rapid volume infusion, which acutely raised pulmonary pressure 
(Pawelczyk et al, 2001); however, sympathoinhibition in that setting is the net effect 
of the integration of multiple reflex inputs. In contrast, experiments in non-hypoxic 
animals demonstrated sympathoexcitation in response to incremental increases in 
pulmonary arterial pressure over a physiological range. Notably, careful control of 
pressure to the aortic and carotid baroreceptors eliminated baroreflex buffering of 
measured response (Moore et al., 2011), something which very difficult to 
accomplish in humans. Second, we investigated sympathetic vasomotor outflow to 
the skeletal muscle vasculature only and acknowledge that outflow to other vascular 
beds may exhibit differential reflex responses (Morrison 2001). Third, under ambient 
conditions, a modified Oxford test was performed prior to a participant being placed 
on the mouthpiece, whereas during the iNO intervention the test was performed 
whilst the subject breathed with a mouthpiece. Breathing through a mouthpiece 
alone, therefore, may have influenced the vascular-sympathetic baroreflex. However, 
MSNA ‘set-point’ was determined from a period when the participants were 
spontaneously breathing through a mouthpiece for both conditions; furthermore, an 
index of spontaneous vascular-sympathetic baroreflex gain was determined during 
these same periods. Notably, inhalation of NO did not alter baroreflex gain, 
regardless of the method of determination.  In our view, therefore, it is unlikely that 
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measure ventilation, which has known influences on MSNA (Hagbarth & Vallbo, 
1968; Somers et al., 1989) and vascular-sympathetic baroreflex gain (Van De Borne 
et al., 2000). However, Scherrer and colleagues (Scherrer et al., 1996) demonstrated 
that a 12 minute inhalation of NO (40ppm), in healthy lowlanders at a similar altitude 
(4559m), had no effect on ventilation or end tidal CO2. Fifth, due to the unknown time 
course of recovery, the order of conditions was not counterbalanced in the present 
study; therefore, we cannot rule out a potential order effect on our results. 
Implications and Significance 
The present study represents an important first step to bridge a gap in evidence 
between human and animal studies. Consistent with data in non-hypoxic 
anaesthetized dogs, MSNA was greater when pulmonary arterial pressure was 
higher in conscious humans, albeit under HA hypoxia. We propose that a sustained 
increase in pulmonary arterial pressure evokes a reflex input to central nervous 
system areas controlling sympathetic vasoconstrictor outflow. This input, therefore, 
acts as signal for sympathetic restraint of hypoxic vasodilatation, thus preserving 
arterial pressure homeostasis at high-altitude. The same pathway could link 
increased right ventricular outflow and elevated pulmonary arterial pressure during 
exercise to sympathetic restraint of muscle blood flow, so that blood pressure is 
maintained. Still, this speculation requires investigation. Furthermore, it is uncertain 
how this input pathway contributes to beat-by-beat control of the vasoconstrictor 
outflow when pulmonary arterial pressure is normal. More study, therefore, is 
required to distinguish low-pressure pulmonary baroreceptor control of sympathetic 
outflow from classical negative feedback reflex control originating from arterial 
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Conclusion 
This study provides evidence that supports a physiological role for pulmonary arterial 
baroreceptors in sympathetic activation in humans, at least when there is a 
sustained elevation in arterial pressure in the pulmonary circulation. Taking 
advantage of a novel experimental approach, we observed a reduction in basal 
MSNA during acute lowering of pulmonary arterial pressure; this is opposite to the 
sympathoexcitatory effect when there is a reduction of systemic arterial pressure. 
Furthermore, lowering arterial pulmonary pressure influences the set-point of the 
vascular sympathetic baroreflex. Finally, this study illustrates some of the technical 
challenges encountered when studying sympathetic neural responses to stimulation 
of different reflex inputs in conscious humans, and highlights the importance of 
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Table 1. Haematological, cardiovascular and pulmonary haemodynamics and muscle sympathetic 
nerve activity (MSNA) during ambient air breathing (Amb) and during inhalation of nitric oxide (iNO). 
Group (n=13) data are presented as mean (± SD) (♦ SpO2 for n=11). Statistical comparisons 






    Amb (n=13)   iNO (n=13)  
P Value 
     
Pulmonary haemodynamics      
Pulmonary systolic artery pressure (mmHg)  32 ± 5 26 ± 4 <0.001 
     
Cardiovascular haemodynamics     
SpO2 (%) ♦   82 ± 3 85 ± 5 0.07 
Heart rate (bpm)   75 ± 18 73 ± 17 0.6 
Systolic BP (mmHg)  130 ± 17 128 ± 17 0.002 
Diastolic BP (mmHg)  82 ± 8 80 ± 8 <0.001 
Mean arterial pressure (mmHg)   101 ± 11 100 ± 11 0.0034 
Stroke volume (mL)  71.4 ± 16.3 73.9 ± 18.3 0.13 
Cardiac output (L·min
-1
)   5.3 ± 1.3 5.3 ± 1.2 0.81 
Total peripheral resistance (mmHg·L·min
-1
)   20.9 ± 5.6 19.9 ± 4.8 0.76 
            
Muscle sympathetic nerve activity         
Burst frequency (bursts·min
-1
)  29 ± 13    23 ± 13 0.008 
Burst incidence (bursts·100HB
-1
)  39 ± 15    33 ± 17 0.01 
Mean burst amplitude (au)  48 ± 11    46 ± 16 0.17 
Total activity (au·min
-1
)  1369 ± 576    994 ± 474 0.01 
Total MSNA (au·100HB
-1
)  1882 ± 862    1479 ± 891 0.02 
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Figure 1. 
Figure 1. Example recording of MSNA and blood pressure. One representative 










Figure 2. Group average pulmonary arterial systolic pressure (PASP) and 
corresponding MSNA total activity during ambient air breathing (Amb) and inhalation 
of nitric oxide (iNO). Grey lines represent each individual’s MSNA response to 
changes in PASP and black line represents average MSNA response to changes in 
PASP. Data from one participant who did not display a change in PASP during iNO 
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Figure 3. Vascular-sympathetic baroreflex function: A) Average regression line 
for relationships (n=10) between DBP and MSNA burst probability and DBP and total 
MSNA from a modified Oxford test during ambient air (Amb) and inhaled nitric oxide 
(iNO). The operating points are indicated by symbols and error bars (mean ± SD) * 
Vascular-sympathetic baroreflex set-point P<0.05 versus Amb. The vascular-
sympathetic baroreflex was reset downward during iNO. The slope of the relationship 
between DBP and MSNA  was similar during Amb and iNO, indicating no difference 
in vascular-sympathetic baroreflex gain (paired t-test). B) Individual and mean (n=10) 
slopes for the relationship between DBP and MSNA burst probability and DBP and 
Total MSNA. 
 
 
 
